Laboratory Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Laboratory Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


Fairfield Market Research’s latest report on the Laboratory Informatics market indicates a strong growth trajectory. The market is projected to grow at a CAGR of 5.7% from 2024 to 2031, reaching US$ 3.57 Bn by 2024 and US$ 5.25 Bn by 2031.

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡

Technological advancements in molecular genomics and genetic testing techniques have significantly increased the amount of data collected by laboratories. This surge in data, along with a growing preference for customized treatments and cancer genomics investigations, is driving the demand for lab automation systems. Additionally, increased patient interaction needs are fueling this growth.

𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤

From 2017 to 2021, the Laboratory Informatics market grew at a CAGR of 5.5%, with North America holding a significant share. The adoption of laboratory automation is expected to accelerate as demand for laboratory informatics solutions rises. Key trends include more user-friendly software solutions, data migration to the cloud, and the increasing number of laboratory informatics companies.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐚𝐭 𝐭𝐡𝐞 𝐅𝐨𝐫𝐞𝐟𝐫𝐨𝐧𝐭

The US leads the North American Laboratory Informatics market, projected to reach USD 2.1 billion by 2032, growing at a 6.1% CAGR during the forecast period. Policies supporting the deployment of laboratory information systems, high digital literacy, and advanced infrastructure are key drivers of this regional market. Additionally, rising healthcare costs and the need to bend the cost curve are promoting greater use of Laboratory Information Management Systems (LIMS).

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐀𝐝𝐨𝐩𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐥𝐨𝐮𝐝 𝐚𝐧𝐝 𝐌𝐨𝐛𝐢𝐥𝐞 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬

The cloud is quickly becoming the standard for laboratory informatics software. Informatics service providers must now have a cloud and SaaS strategy to stay competitive. Additionally, the number of research laboratories using cloud, mobile, and voice technologies is growing, driving further demand for lab automation solutions.

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬

While stringent regulations pose challenges to the deployment of lab automation, they also present development opportunities. The increasing use of robots and automation technologies in healthcare is making procedures more reproducible and predictable, allowing for faster setup, execution, and analysis of experimental data. High throughput technologies are enhancing the efficiency of laboratory operations, contributing to overall market growth.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬: 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧

Technological advancements and increasing economic demands have led to the rapid accumulation of large volumes of data from various research and development activities, quality assurance, and manufacturing processes. This trend is expected to continue, with laboratory informatics playing a crucial role in ensuring high-quality, reliable experiment data that meets industry regulatory standards.

The US remains at the forefront of Laboratory Informatics market revenue, driven by well-established pharmaceutical businesses and the need to manage and analyze information efficiently. As the market evolves, the adoption of innovative technologies and solutions will be critical to maintaining growth and competitiveness.

Key Market Players:
•THERMO FISHER SCIENTIFIC, INC.
•CORE INFORMATICS
•LABWARE
•PERKINELMER, INC.
•LABVANTAGE SOLUTIONS, INC.
•LABLYNX, INC.
•AGILENT TECHNOLOGIES
•ID BUSINESS SOLUTIONS LTD.
•MCKESSON CORPORATION
•WATERS CORPORATION
•ABBOTT INFORMATICS



Market Segments Covered in Laboratory Informatics Market Analysis:

By Product Type
•Laboratory Information Management Systems (LIMS)
•Electronic Lab Notebooks (ELN)
•Scientific Data Management Systems (SDMS)
•Laboratory Execution Systems (LES)
•Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
•Chromatography Data Systems (CDS)
•Enterprise Content Management (ECM)
•Sclerotherapy
•Cellulite Treatment

By Deployment Mode
•On-premise
•Web-hosted
•Cloud-based

By Component
•Software
•Services

By End- user
•Life Sciences
•CROs
•Chemical Industry
•F&B and Agriculture
•Environmental Testing Labs
•Petrochemical Refineries & Oil and Gas Industry
•Other End-Users

By Region
•North America
•Latin America
•Europe
•APAC
•MEA





Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global RNA Analysis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global RNA Analysis Market Outlook, 2018 – 2031
3.1. Global RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Instruments
3.1.1.2. Kits & Reagents
3.1.1.2.1. miRNA & siRNA
3.1.1.2.2. Reverse Transcriptase & RT-PCR
3.1.1.2.3. RNA Extraction & Purification
3.1.1.2.4. RNA Interference
3.1.1.2.5. Others
3.1.1.3. Services
3.2. Global RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Real Time-PCR (qPCR) Technology
3.2.1.2. Microarray Technology
3.2.1.3. Sequencing Technology
3.2.1.4. Others
3.3. Global RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Construction of RNA Expression Atlas
3.3.1.2. Epigenetics
3.3.1.3. Infectious Diseases and Pathogenesis
3.3.1.4. Alternative RNA Splicing
3.3.1.5. RNA Structure & Molecular Dynamics
3.3.1.6. Development & Delivery of RNA Therapeutics
3.3.1.7. Others
3.4. Global RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. Government Institutes & Academic Centers
3.4.1.2. Pharmaceutical & Biotechnology Companies
3.4.1.3. Contract Research Organizations (CROs)
3.4.1.4. Hospitals & Clinics
3.5. Global RNA Analysis Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America RNA Analysis Market Outlook, 2018 – 2031
4.1. North America RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
4.1.1. Key Highlights
4.1.1.1. Instruments
4.1.1.2. Kits & Reagents
4.1.1.2.1. miRNA & siRNA
4.1.1.2.2. Reverse Transcriptase & RT-PCR
4.1.1.2.3. RNA Extraction & Purification
4.1.1.2.4. RNA Interference
4.1.1.2.5. Others
4.1.1.3. Services
4.2. North America RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
4.2.1. Key Highlights
4.2.1.1. Real Time-PCR (qPCR) Technology
4.2.1.2. Microarray Technology
4.2.1.3. Sequencing Technology
4.2.1.4. Others
4.3. North America RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
4.3.1. Key Highlights
4.3.1.1. Construction of RNA Expression Atlas
4.3.1.2. Epigenetics
4.3.1.3. Infectious Diseases and Pathogenesis
4.3.1.4. Alternative RNA Splicing
4.3.1.5. RNA Structure & Molecular Dynamics
4.3.1.6. Development & Delivery of RNA Therapeutics
4.3.1.7. Others
4.4. North America RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
4.4.1. Key Highlights
4.4.1.1. Government Institutes & Academic Centers
4.4.1.2. Pharmaceutical & Biotechnology Companies
4.4.1.3. Contract Research Organizations (CROs)
4.4.1.4. Hospitals & Clinics
4.5. North America RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
4.5.1. Key Highlights
4.5.1.1. U.S. RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
4.5.1.2. U.S. RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
4.5.1.3. U.S. RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
4.5.1.4. U.S. RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
4.5.1.5. Canada RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
4.5.1.6. Canada RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
4.5.1.7. Canada RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
4.5.1.8. Canada RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
4.5.2. Market Attractiveness Analysis
5. Europe RNA Analysis Market Outlook, 2018 – 2031
5.1. Europe RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Instruments
5.1.1.2. Kits & Reagents
5.1.1.2.1. miRNA & siRNA
5.1.1.2.2. Reverse Transcriptase & RT-PCR
5.1.1.2.3. RNA Extraction & Purification
5.1.1.2.4. RNA Interference
5.1.1.2.5. Others
5.1.1.3. Services
5.2. Europe RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Real Time-PCR (qPCR) Technology
5.2.1.2. Microarray Technology
5.2.1.3. Sequencing Technology
5.2.1.4. Others
5.3. Europe RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Construction of RNA Expression Atlas
5.3.1.2. Epigenetics
5.3.1.3. Infectious Diseases and Pathogenesis
5.3.1.4. Alternative RNA Splicing
5.3.1.5. RNA Structure & Molecular Dynamics
5.3.1.6. Development & Delivery of RNA Therapeutics
5.3.1.7. Others
5.4. Europe RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. Government Institutes & Academic Centers
5.4.1.2. Pharmaceutical & Biotechnology Companies
5.4.1.3. Contract Research Organizations (CROs)
5.4.1.4. Hospitals & Clinics
5.5. Europe RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
5.5.1. Key Highlights
5.5.1.1. Germany RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.2. Germany RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.3. Germany RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.4. Germany RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
5.5.1.5. U.K. RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.6. U.K. RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.7. U.K. RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.8. U.K. RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
5.5.1.9. France RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.10. France RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.11. France RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.12. France RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
5.5.1.13. Italy RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.14. Italy RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.15. Italy RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.16. Italy RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
5.5.1.17. Turkey RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.18. Turkey RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.19. Turkey RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.20. Turkey RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.21. Russia RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.22. Russia RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.23. Russia RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.24. Russia RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.25. Rest of Europe RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
5.5.1.26. Rest of Europe RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
5.5.1.27. Rest of Europe RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.1.28. Rest of Europe RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
5.5.2. Market Attractiveness Analysis
6. Asia Pacific RNA Analysis Market Outlook, 2018 – 2031
6.1. Asia Pacific RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Instruments
6.1.1.2. Kits & Reagents
6.1.1.2.1. miRNA & siRNA
6.1.1.2.2. Reverse Transcriptase & RT-PCR
6.1.1.2.3. RNA Extraction & Purification
6.1.1.2.4. RNA Interference
6.1.1.2.5. Others
6.1.1.3. Services
6.2. Asia Pacific RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Real Time-PCR (qPCR) Technology
6.2.1.2. Microarray Technology
6.2.1.3. Sequencing Technology
6.2.1.4. Others
6.3. Asia Pacific RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Construction of RNA Expression Atlas
6.3.1.2. Epigenetics
6.3.1.3. Infectious Diseases and Pathogenesis
6.3.1.4. Alternative RNA Splicing
6.3.1.5. RNA Structure & Molecular Dynamics
6.3.1.6. Development & Delivery of RNA Therapeutics
6.3.1.7. Others
6.4. Asia Pacific RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. Government Institutes & Academic Centers
6.4.1.2. Pharmaceutical & Biotechnology Companies
6.4.1.3. Contract Research Organizations (CROs)
6.4.1.4. Hospitals & Clinics
6.5. Asia Pacific RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
6.5.1. Key Highlights
6.5.1.1. China RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.2. China RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.3. China RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.4. China RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.1.5. Japan RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.6. Japan RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.7. Japan RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.8. Japan RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.1.9. South Korea RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.10. South Korea RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.11. South Korea RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.12. South Korea RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.1.13. India RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.14. India RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.15. India RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.16. India RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.1.17. Southeast Asia RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.18. Southeast Asia RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.19. Southeast Asia RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.20. Southeast Asia RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.1.21. Rest of Asia Pacific RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
6.5.1.22. Rest of Asia Pacific RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
6.5.1.23. Rest of Asia Pacific RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
6.5.1.24. Rest of Asia Pacific RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
6.5.2. Market Attractiveness Analysis
7. Latin America RNA Analysis Market Outlook, 2018 – 2031
7.1. Latin America RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Instruments
7.1.1.2. Kits & Reagents
7.1.1.2.1. miRNA & siRNA
7.1.1.2.2. Reverse Transcriptase & RT-PCR
7.1.1.2.3. RNA Extraction & Purification
7.1.1.2.4. RNA Interference
7.1.1.2.5. Others
7.1.1.3. Services
7.2. Latin America RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Real Time-PCR (qPCR) Technology
7.2.1.2. Microarray Technology
7.2.1.3. Sequencing Technology
7.2.1.4. Others
7.3. Latin America RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Construction of RNA Expression Atlas
7.3.1.2. Epigenetics
7.3.1.3. Infectious Diseases and Pathogenesis
7.3.1.4. Alternative RNA Splicing
7.3.1.5. RNA Structure & Molecular Dynamics
7.3.1.6. Development & Delivery of RNA Therapeutics
7.3.1.7. Others
7.4. Latin America RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Government Institutes & Academic Centers
7.4.1.2. Pharmaceutical & Biotechnology Companies
7.4.1.3. Contract Research Organizations (CROs)
7.4.1.4. Hospitals & Clinics
7.5. Latin America RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
7.5.1. Key Highlights
7.5.1.1. Brazil RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
7.5.1.2. Brazil RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
7.5.1.3. Brazil RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
7.5.1.4. Brazil RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
7.5.1.5. Mexico RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
7.5.1.6. Mexico RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
7.5.1.7. Mexico RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
7.5.1.8. Mexico RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
7.5.1.9. Argentina RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
7.5.1.10. Argentina RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
7.5.1.11. Argentina RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
7.5.1.12. Argentina RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
7.5.1.13. Rest of Latin America RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
7.5.1.14. Rest of Latin America RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
7.5.1.15. Rest of Latin America RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
7.5.1.16. Rest of Latin America RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
7.5.2. Market Attractiveness Analysis
8. Middle East & Africa RNA Analysis Market Outlook, 2018 – 2031
8.1. Middle East & Africa RNA Analysis Market Outlook, By Product Type, Value (US$ Bn), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Instruments
8.1.1.2. Kits & Reagents
8.1.1.2.1. miRNA & siRNA
8.1.1.2.2. Reverse Transcriptase & RT-PCR
8.1.1.2.3. RNA Extraction & Purification
8.1.1.2.4. RNA Interference
8.1.1.2.5. Others
8.1.1.3. Services
8.2. Middle East & Africa RNA Analysis Market Outlook, By Technology, Value (US$ Bn), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Real Time-PCR (qPCR) Technology
8.2.1.2. Microarray Technology
8.2.1.3. Sequencing Technology
8.2.1.4. Others
8.3. Middle East & Africa RNA Analysis Market Outlook, By Application, Value (US$ Bn), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Construction of RNA Expression Atlas
8.3.1.2. Epigenetics
8.3.1.3. Infectious Diseases and Pathogenesis
8.3.1.4. Alternative RNA Splicing
8.3.1.5. RNA Structure & Molecular Dynamics
8.3.1.6. Development & Delivery of RNA Therapeutics
8.3.1.7. Others
8.4. Middle East & Africa RNA Analysis Market Outlook, By End-use, Value (US$ Bn), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. Government Institutes & Academic Centers
8.4.1.2. Pharmaceutical & Biotechnology Companies
8.4.1.3. Contract Research Organizations (CROs)
8.4.1.4. Hospitals & Clinics
8.5. Middle East & Africa RNA Analysis Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
8.5.1. Key Highlights
8.5.1.1. GCC RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
8.5.1.2. GCC RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
8.5.1.3. GCC RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
8.5.1.4. GCC RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
8.5.1.5. South Africa RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
8.5.1.6. South Africa RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
8.5.1.7. South Africa RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
8.5.1.8. South Africa RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
8.5.1.9. Egypt RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
8.5.1.10. Egypt RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
8.5.1.11. Egypt RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
8.5.1.12. Egypt RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
8.5.1.13. Nigeria RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
8.5.1.14. Nigeria RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
8.5.1.15. Nigeria RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
8.5.1.16. Nigeria RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
8.5.1.17. Rest of Middle East & Africa RNA Analysis Market By Product Type, Value (US$ Bn), 2018 – 2031
8.5.1.18. Rest of Middle East & Africa RNA Analysis Market By Technology, Value (US$ Bn), 2018 – 2031
8.5.1.19. Rest of Middle East & Africa RNA Analysis Market By Application, Value (US$ Bn), 2018 – 2031
8.5.1.20. Rest of Middle East & Africa RNA Analysis Market By End-use, Value (US$ Bn), 2018 – 2031
8.5.2. Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Application vs By Technology Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Agilent Technologies Inc
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Bio-Rad Laboratories Inc
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. F.Hoffman-La Roche Ltd
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. IllUMINA Inc
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. QIAGEN
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Thermo Fisher Scientific
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Danaher Corporation
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Lexogen GmbH
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Eurofins Scientific
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Merck KGaA
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings